Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Alcohol consumption has been linked positively to tumors of the mouth, esophagus, pancreas, liver, and breast, salt or salted foods to gastric tumors, red or processed meats to colorectal or gastric cancers, and aflatoxin to liver tumors
Diabetic patients presented thickened vascular walls
Xu Q, Mei S, Nie F, Zhang Z, Feng J, Zhang J, et al
Identifying such trends, which are often buried in the hurly-burly of daily information, and deciding how they can contribute to the development of education is a priority task for the planners and decision-makers of national research bodies and of those regional or international organizations for which education is an insti- tutional field of competence